6
Jan 2026
The American Society for Radiation Oncology (ASTRO) announced today that it rebranded its research foundation, formerly the Radiation Oncology Institute (ROI), as Speed of Light – The ASTRO Foundation, marking a new chapter in ASTRO's commitment to advancing research and improving patient care in radiation oncology.
6
Jan 2026
For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease prevention or slowing, rather than recovery.
6
Jan 2026
Nurses in critical care units who perceive higher levels of teamwork with their colleagues are more likely to take breaks during their shifts, according to new research from The Center for Health Design published in American Journal of Critical Care (AJCC).
6
Jan 2026
About half of older men suffer from sleep problems, back pain or both, according to Soomi Lee, associate professor of human development and family studies at Penn State.
6
Jan 2026
On Jan. 5, the Centers for Disease Control and Prevention (CDC) dramatically reduced the number of recommended childhood vaccinations from 17 to 11, citing practices in other wealthy nations, including Denmark, Germany, and Japan.
6
Jan 2026
A groundbreaking new study from Bar-Ilan University shows that one of sleep's core functions originated hundreds of millions of years ago in jellyfish and sea anemones, among the earliest creatures with nervous systems.
6
Jan 2026
Simple pharmaceutical interventions could help older brains cope with memory impairment and recovery after surgery, new studies in mice suggest.
6
Jan 2026
Finger-prick dried blood sampling can accurately measure key Alzheimer’s disease biomarkers, including p-tau217, GFAP, and NfL, showing strong concordance with venous plasma and meaningful associations with CSF pathology. While analytical limitations remain, this minimally invasive approach shows promise as a scalable research and screening tool within biomarker-based diagnostic pathways.
6
Jan 2026
Detecting cancer in the earliest stages could dramatically reduce cancer deaths because cancers are usually easier to treat when caught early.
6
Jan 2026
A new study co-led by the Southern California Superfund Research and Training Program for PFAS Assessment, Remediation and Prevention (ShARP) Center and the University of Hawai'i has linked certain common "forever chemicals" to a higher risk of liver disease in adolescents.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
